Drug Shortage Report for KEVZARA
Report ID | 189382 |
Drug Identification Number | 02472961 |
Brand name | KEVZARA |
Common or Proper name | KEVZARA 150MG |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SARILUMAB |
Strength(s) | 150MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 2 |
ATC code | L04AC |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-04-12 |
Estimated end date | 2023-07-31 |
Actual end date | 2023-08-15 |
Shortage status | Resolved |
Updated date | 2023-08-16 |
Company comments | There is significant inventory at the wholesaler to meet patient needs. If you have any issues obtaining Kevzara 150mg Auto Injector please contact Customer Support at LAVALCS@sanofi.com. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-08-16 | English | Compare |
v9 | 2023-08-15 | French | Compare |
v8 | 2023-08-15 | English | Compare |
v7 | 2023-04-21 | French | Compare |
v6 | 2023-04-21 | English | Compare |
v5 | 2023-04-13 | English | Compare |
v4 | 2023-04-12 | French | Compare |
v3 | 2023-04-12 | English | Compare |
v2 | 2023-04-12 | French | Compare |
v1 | 2023-04-12 | English | Compare |
Showing 1 to 10 of 10